$0.5810
-0.0043-0.73%
At close: Sep 11, 5:00 PM EST
$0.5842
0.00320.55%
After Hours: 7:10 PM EST

Citius Pharmaceuticals (CTXR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.32 | $-0.30 | $-0.24 |
| Actual | $-0.34 | $-0.99 | $-0.38 | $-0.11 |
| Surprise | +5.56% | -210.9% | -26.7% | +54.2% |
| Revenue | ||||
| Estimate | $5.5M | $9.9M | $3.5M | $5.8M |
| Actual | $1.5M | $1.7M | $3.9M | $0 |
| Surprise | -72.7% | -83.1% | +14.1% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.41 | $-0.38 | $-0.38 | $-0.38 |
| Revenue | ||||
| Consensus | $2.9M | $4.4M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $-0.34 | $-0.36 | 5.56 % |
| Q2 | May 15, 2026 | $-1.00 | $-0.32 | -210.9 % |
| Q1 | Feb 13, 2026 | $-0.38 | $-0.30 | -26.7 % |
| Q4 | Dec 23, 2025 | $-0.11 | $-0.24 | 54.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $1.49M | $5.47M | -72.7 % |
| Q2 | May 15, 2026 | $1.67M | $9.87M | -83.1 % |
| Q1 | Feb 13, 2026 | $3.94M | $3.46M | 14.1 % |
| Q4 | Dec 23, 2025 | $0 | $5.76M | -100.0 % |